LIGAND PHARMACEUTICALS INCORPORATED
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2025
Total Assets: $1.56B
Liabilities Breakdown FY2025
Total Liabilities: $543.4M
Asset Breakdown
Total Assets: $1.56B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $174.9M | 11.2% |
| Accounts Receivable | $59.6M | 3.8% |
| Inventory | $9.1M | 0.6% |
| Property, Plant & Equipment | $3.6M | 0.2% |
| Goodwill | $101.5M | 6.5% |
| Intangible Assets | $225.4M | 14.4% |
| Other Assets | $986.4M | 63.2% |
Liabilities Breakdown
Total Liabilities: $543.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.2M | 0.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $540.2M | 99.4% |